| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL)
MDGL Technical Analysis
5
| As on 9th Jun 2023 MDGL STOCK Price closed @ 265.53 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 75.04 & Strong Buy for SHORT-TERM with Stoploss of 80.72 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MDGLSTOCK Price
| Open | 268.82 | Change | Price | % |
| High | 274.10 | 1 Day | -3.67 | -1.36 |
| Low | 263.74 | 1 Week | -12.88 | -4.63 |
| Close | 265.53 | 1 Month | -39.26 | -12.88 |
| Volume | 186800 | 1 Year | 184.77 | 228.79 |
| 52 Week High 312.00 | 52 Week Low 55.89 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MDGL Daily Charts |
MDGL Intraday Charts |
Whats New @ Bazaartrend |
MDGL Free Analysis |
|
|
MDGL Important Levels Intraday
| RESISTANCE | 285.49 |
| RESISTANCE | 279.09 |
| RESISTANCE | 275.13 |
| RESISTANCE | 271.18 |
| SUPPORT | 259.88 |
| SUPPORT | 255.93 |
| SUPPORT | 251.97 |
| SUPPORT | 245.57 |
MDGL Forecast April 2024
| 4th UP Forecast | 348.31 |
| 3rd UP Forecast | 321.76 |
| 2nd UP Forecast | 305.35 |
| 1st UP Forecast | 288.94 |
| 1st DOWN Forecast | 242.12 |
| 2nd DOWN Forecast | 225.71 |
| 3rd DOWN Forecast | 209.3 |
| 4th DOWN Forecast | 182.75 |
MDGL Weekly Forecast
| 4th UP Forecast | 286.84 |
| 3rd UP Forecast | 280.01 |
| 2nd UP Forecast | 275.78 |
| 1st UP Forecast | 271.56 |
| 1st DOWN Forecast | 259.50 |
| 2nd DOWN Forecast | 255.28 |
| 3rd DOWN Forecast | 251.05 |
| 4th DOWN Forecast | 244.22 |
MDGL Forecast2024
| 4th UP Forecast | 786.48 |
| 3rd UP Forecast | 619.41 |
| 2nd UP Forecast | 516.14 |
| 1st UP Forecast | 412.87 |
| 1st DOWN Forecast | 118.19 |
| 2nd DOWN Forecast | 14.92 |
| 3rd DOWN Forecast | -88.35 |
| 4th DOWN Forecast | -255.42 |
Madrigal Pharmaceuticals Inc ( NASDAQ USA Symbol : MDGL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MDGL Business Profile
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is MGL-3196, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania. Address: Four Tower Bridge, West Conshohocken, PA, United States, 19428
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service